PALB2, partner and localizer of BRCA2, 79728
N. diseases: 260; N. variants: 410
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.790 | 0.280 | 16 | 23621362 | stop gained | C/T | snv | 6.0E-05 | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.730 | 1.000 | 5 | 2010 | 2016 | ||||||
|
0.882 | 0.080 | 16 | 23636036 | frameshift variant | CT/- | delins | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 4 | 2010 | 2018 | |||||||
|
0.807 | 0.240 | 16 | 23614089 | frameshift variant | T/- | delins | 1.2E-05 | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||
|
0.925 | 0.120 | 16 | 23638116 | stop gained | A/C | snv | 8.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | ||||||||||
|
0.925 | 0.080 | 16 | 23633265 | intron variant | A/C;G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2008 | 2018 | ||||||||
|
0.925 | 0.080 | 16 | 23629831 | stop gained | G/A | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||||
|
0.882 | 0.080 | 16 | 23637886 | frameshift variant | ACAA/- | delins | 4.0E-05 | 3.5E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
|
0.925 | 0.080 | 16 | 23613903 | intron variant | T/C | snv | 0.13 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||||
|
0.925 | 0.080 | 16 | 23629146 | intron variant | G/A | snv | 0.31 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2008 | 2016 | |||||||
|
0.925 | 0.080 | 16 | 23622102 | intron variant | C/G | snv | 0.13 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.925 | 0.080 | 16 | 23614091 | stop gained | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2010 | 2013 | ||||||||
|
0.925 | 0.080 | 16 | 23618750 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 16 | 23638074 | missense variant | A/G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 16 | 23636036 | frameshift variant | CT/- | delins |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 16 | 23635519 | stop gained | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.200 | 16 | 23629897 | stop gained | G/A;T | snv | 2.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 16 | 23636036 | frameshift variant | CT/- | delins |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 16 | 23635917 | missense variant | G/A | snv | 4.8E-03 | 2.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.080 | 16 | 23630235 | stop gained | G/C;T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 16 | 23641204 | 5 prime UTR variant | C/T | snv | 4.0E-02 | 5.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.851 | 0.160 | 16 | 23621428 | missense variant | A/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |